http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1110443-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
filingDate 2008-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_629216a700af8b82060670364e41764e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_194841c54f4d8e89ee80b072a3722e2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a15ec04cb79c01c7f55830083b658356
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c6bb07a98abea3f75c539e8bc29f8b2
publicationDate 2015-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CY-1110443-T1
titleOfInvention Substituted benzopyranas as selective estrogen receptor-beta receptors
abstract The present invention relates to novel heterocyclic compounds which are antagonists of the melanin concentration hormone receptor 1 (MCHR1), also referred to as 11CBy, in pharmaceutical compositions containing them, in processes for their preparation, and in their use in medicaments. The compounds of the invention have the formula (I).
priorityDate 2003-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403639
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25149
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2100
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID443066
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID452964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426098868
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13983
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395575
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100170205
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100534515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6325610
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281146

Total number of triples: 42.